Cargando…
A Case Report of Posttransplant Lymphoproliferative Disorder After AstraZeneca Coronavirus Disease 2019 Vaccine in a Heart Transplant Recipient
We report a case of a heart transplant recipient who presented with a rapidly growing Epstein-Barr virus (EBV)–positive, diffuse large B-cell lymphoma 7 days after receiving the first dose of the ChAdOx1 nCoV-19 vaccine. Because of the atypical radiologic presentation, the initial tentative diagnosi...
Autores principales: | Tang, Wen-Ruei, Hsu, Che-Wei, Lee, Chia-Chi, Huang, Wei-Li, Lin, Chia-Ying, Hsu, Ya-Ting, Chang, Chen, Tsai, Meng-Ta, Hu, Yu-Ning, Hsu, Chih-Hsin, Chen, Po-Lin, Chow, Nan-Haw, Roan, Jun-Neng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481090/ https://www.ncbi.nlm.nih.gov/pubmed/34702598 http://dx.doi.org/10.1016/j.transproceed.2021.09.006 |
Ejemplares similares
-
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021) -
Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021) -
Vaccin Oxford/AstraZeneca, mode d’emploi
por: Dalmat, Yann-Mickael
Publicado: (2021) -
Oxford–AstraZeneca COVID-19 vaccine efficacy
por: Knoll, Maria Deloria, et al.
Publicado: (2021) -
AstraZeneca COVID-19 vaccine-related thromboembolism
Publicado: (2021)